Curative surgery for atrial fibrillation: Current status and minimally invasive approaches

Minerva Cardioangiologica

Volumn 52, Issue 2, 2004, Pages 155-168

  Navia, J L ^a   Gillinov, A M ^a   McCarthy, P M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Heart, surgery; Pulmonary veins

Indexed keywords

CATHETER ABLATION; CLINICAL TRIAL; DEATH; DISEASE ASSOCIATION; EPIDEMIC; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; MINIMALLY INVASIVE CARDIAC SURGERY; OPERATION DURATION; PATHOGENESIS; PULMONARY VEIN; REVIEW; RISK; SAFETY; STROKE; SURGEON; SURGICAL TECHNIQUE; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; ENDOSCOPY; EQUIPMENT DESIGN; HEART ATRIA; HUMANS; PULMONARY VEINS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 2942702006     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Feinberg WM, Blackshear JL, Laupacias A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-73.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. The Framingham study. N Engl J Med 1982;306:1018-22.
3. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular health study). Am J Cardiol 1994;74:236-41.
4. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. JAMA 2001;285:2370-5.
5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannal WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham heart study. Circulation 1998;98:946-52.
6. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9.
7. Pedersen CT, for the DIAMOND Study Group. The effect of atrial fibrillation/flutter on all-cause mortality in patients with heart failure or myocardial infraction with left ventricular dysfunction. PACE 1999;22:II-719.
8. Stroke risk factors and their impact. Englewood, CO: National Stroke Association; 1999.
9. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001;104:2118-50.
10. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1999;22:983-8.
11. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119 Suppl:194S-206.
12. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. for the AFFIRM writing group. A comparison of rate control and rhythm control in patients with atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators. N Engl J Med 2002;347:1825-33.
13. Maglio C, Ayers GM, Tidball EW, Sra J, Dhala A, Blanck Z et al. Health care utilization and cost of care in patients with symptomatic atrial fibrillation. Circulation 1996;94:I-169.
14. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Mortality and hospital costs associated with atrial fibrillation. Circulation 1995;92 Suppl I:I-140.
15. Haisaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
16. Marrouche NF, Dresing T, Cole C, Bash D, Saad E, Balaban K. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol 2002;40:464-74.
17. Chen SA. Catheter ablation of atrial fibrillation: fact and controversy. J Cardiovasc Electrophsyiol 2002;13:2074-5.
18. Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhoffer II. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;102:2463-5.
19. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-81.
20. Marrouche NF, Dresing T, Cole C, Bash D, Saad E, Balaban K et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation. J Am Coll Cardiol 2002;40:464-74.
21. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P. Mortality, morbidity and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J Am Coll Cardiol 2003;42:185-97.
22. Cox JL, Schuessler RB, D'Agostino HJ jr, Stone CM, Chang BC, Cain ME et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-83.
23. Cox JL, Schuessler RB, Boineau JP. The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000;12:2-14.
24. Cox JL, Boineau JP, Schuessler RB, Kater KM, Ferguson TB Jr, Cain ME et al. Electrophysiologic basis, surgical development, and clinical results of the Maze procedure for atrial flutter and atrial fibrillation. Adv Card Surg 1995;6:1-67.
25. rd, Camillo CJ, Cox JL. The Maze procedure for cure of atrial fibrillation. Cardiol Clin 1997;15:739-48.
26. Cox JL, Ad N, Palazzo T, Fitzpatrick S, Suyderhoud TP, DeGroot KW et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000;12:15-9.
27. Harada A, Sasaki K, Fukushima T, Ikeshita M, Asano T, Yamauchi S et al. Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease. Ann Thorac Surg 1996;61:104-12.
28. Nitta T, Imura H, Bessho R, Hosaka H, Yamauchi S, Tanaka S. Wavelength and conduction inhomogeneity in each atrium in patients with isolated mitral valve disease and atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:521-8.
29. Sueda T, Nagata H, Orihashi K, Morita S, Okada K, Sueshiro M et al. Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations. Ann Thorac Surg 1997;63:1070-5.
30. Sueda T, Nagata H, Shikata H, Orihashi K, Morita S, Sueshiro M et al. Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease. Ann Thorac Surg 1996;62:1796-800.
31. Gillinov AM, Blackstone EH, McCarthy PM. Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg 2002;74:2210-7.
32. Gillinov AM, McCarthy PM. Atricure bipolar radiofrequency clamp for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 1002;74:2165-8.
33. rd. Microwave ablation of atrial fibrillation during mitral valve operations. Ann Thorac Surg 2002;74:1259-61.
34. Gillinov AM, McCarthy PM, Marrouche N, Natale A. Contemporary surgical treatment for atrial fibrillation. PACE 2003;26:1-4.
35. Sie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ, Wellens HJ. The radiofrequency modified Maze procedure. A less invasive approach to atrial fibrillation during open-heart surgery. Eur J Cardiothorac Surg 2001;19:443-7.
36. Mohr FW, Fabricius AM, Falk V, Autschbach R, Doll N, Von Oppell U et al. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: Short-term and midterm results. J Thorac Cardiovasc Surg 2002;123:919-27.
37. Williams MR, Stewart JR, Bolling SF, Freeman S, Anderson JT, Argenziano M et al. Surgical treatment of atrial fibrillation using radiofrequency energy. Ann Thorac Surg 2001;71:1939-44.
38. Kress DC, Krum D, Chekanov, Hare J, Michaud N, Akhtar M et al. Validation of a left atrial lesion pattern for intraoperative ablation of atrial fibrillation. Ann Thorac Surg 2002;73:1160-8.
39. Cox JL, Ad N. New surgical and catheter-based modifications of the Maze procedure. Semin Thorac Cardiovasc Surg 2000;12:68-73.
40. Cox JL. The minimally invasive Maze-III procedure. Oper Tech Thorac Cardiovasc Surg 2000;5:79-92.
41. rd. The Cox-Maze procedure: The Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 2000;12:25-9.
42. Schaff HV, Dearani JA, Daly RC, Orszulak TA, Danielson GK. Cox-Maze procedure for atrial fibrillation: Mayo Clinic Experience. Semin Thorac Cardiovasc Surg 2002;12:30-7.
43. Arcidi JM Jr, Doty DB, Millar RC. The Maze procedure: The LDS Hospital experience. Semin Thorac Cardiovasc Surg 2000;12:38-43.
44. Cox JL, Jaquiss RD, Schuessler RB, Boineau JP. Modifications of the Maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the Maze III procedure. J Thorac Cardiovasc Surg 1995;110:485-95.
45. Ad N, Cox JL. Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2001;12:56-62.
46. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067-78.
47. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26.
48. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of the human hearts. Circulation 1966;34:412-22.
49. Hindricks G, Mohr FW, Autschbach R, Kottkamp H. Antiarrhythmic surgery for treatment of atrial fibrillation: new concepts. Thorac Cardiovasc Surg 1999;47 Suppl 3:365-9.
50. Shimoike E, Kaji Y, Ueda N, Maruyama T, Kanaya S, Niho Y. In vivo and in vitro study of radio-frequency application with a new long linear probe: implications for the Maze operation. J Thorac Cardiovasc Surg 2000;120:164-72.
51. Thomas SP, Duncan JR, Boyd AC, Eipper VE, Ross DL, Chard RB. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg 2003;75:543-8.
52. Saltman AE, Rosenthal LS, Francalancia NA, Lahey SL. A complete endoscopic approach to microwave ablation for atrial fibrillation. Heart Surg Forum 2003;6:E38-41.
53. Kottkamp H, Hindricks G, Hammel D, Autschbach R, Mergenthaler J, Borggrete M et al. Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic "anchor" reentrant circuits. J Cardiovasc Electrophysiol 1999;10:772-80.
54. Pasic M, Bergs P, Muller P, Hofmann M, Grauhan O, Kuppe H et al. Intraoperative radiofrequency Maze ablation for atrial fibrillation: The Berlin Modification. Ann Thorac Surg 2001;72:1484-91.
55. Cox JL, Ad N. The importance of cryoablation of the coronary sinus during the Maze procedure. Semin Thorac Cardiovasc Surg 2000;12:20-4.
56. Raanani E, Albage A, David TE, Yau TM, Armstrong S. The efficacy of the Cox-Maze procedure combined with mitral valve surgery: a matched control study. Eur J Cardiothorac Surg 2001;438-42.
57. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriguez-Sarano M. Outcome of a valve repair and the Cox Maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg 1999;118:628-35.
58. Chen MC, Chang JP, Guo GB, Chang HW. Atrial size reduction as a predictor of the success of radiofrequency Maze procedure for chronic atrial fibrillation in patients undergoing concomitant valvular surgery. J Cardiovasc Electrophysiol 2001;12:867-74.
59. Damiano RJ Jr. Alternative energy sources for atrial ablation: judging the new technology. Ann Thorac Surg 2003;75:329-30.
60. th International Workshop on Cardiac Arrythmias. Venice, Italy. October 5-8, 2003.